About this event
Transform regulatory, quality, and clinical processes from weeks to days, securely, compliantly, and at scale.
Together with our guest speakers from Deloitte, we will discuss how AI is redefining productivity for the life sciences industry. Generis will demonstrate CARA AI, an AI platform fully embedded in the CARA Life Sciences Platform, bringing enterprise security, user-level permissions, and full auditability. This means you can safely apply AI to your most sensitive regulatory, clinical, and quality workflows without risking compliance. In this exclusive webinar, Deloitte will share insights on the business value of AI in R&D and discuss AI compliance standards to deliver measurable value.
What You’ll Learn
State-of-the industry – a few years into GenAI, most prominent & successful use cases and lessons learned
Built-in AI for secure and compliant automation across RIM, eTMF, Health Authority correspondence, and more.
Process and data semantics: how your existing system architecture underpins successful AI deployment, ensuring compliance and resilience.
The role of CARA AI in enterprise architecture: seamlessly embedding AI into existing systems to avoid disruption while maximising value.
How semantic comparisons, AI-generated summaries, and “chat-with-data” features transform decision-making in regulated environments.
Human-in-the-loop frameworks to keep oversight, accuracy, and regulatory compliance at the centre of AI-driven processes.
This session is designed for professionals in pharmaceutical companies, including:
Reserve Your Spot : Don’t miss the opportunity to see how CARA AI and Deloitte can help you accelerate R&D and streamline compliance without compromising security or quality. If you are unavailable at this time, you can register anyway and you will receive a link to watch on-demand when you are free.